Aspergillosis, Allergic Bronchopulmonary clinical trials

The registry lists 42 studies for Aspergillosis, Allergic Bronchopulmonary across more than 10 countries. 13 are recruiting or about to start. 28 of them are mainly about Aspergillosis, Allergic Bronchopulmonary (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-01.

Get an email when these change. Save the Aspergillosis, Allergic Bronchopulmonary studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 20
Recruiting: 10
Terminated: 4
Not yet recruiting: 3
Withdrawn: 2
No longer available: 1

Phase

Phase 2: 13
Phase 3: 10
Phase 1: 2
Phase 4: 2

Where

India: 11
China: 11
United States: 10
United Kingdom: 9
France: 8
Germany: 5

Who runs them

Qianfoshan Hospital (9) · Post Graduate Institute of Medical Education and Research, Chandigarh (9) · Novartis Pharmaceuticals (2) · GlaxoSmithKline (2) · University of Pittsburgh (2) · Pulmatrix Inc. (2) · Radboud University Medical Center (1) · Scynexis, Inc. (1)

What is being tested here

Drugs under test in Aspergillosis, Allergic Bronchopulmonary studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Itraconazole	2	3	6
Prednisolone	1	2	2
Depemokimab	1	0	1
Tezepelumab	1	0	1
Prednisone	1	0	1
Voriconazole	0	1	2
Amphotericin B	0	1	2
Omalizumab	0	0	2
Deflazacort	0	1	1
Dupilumab	0	0	1

Drug classes tested here Corticosteroids 2 open

Coming up

2phase 3 studies under way

4studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4

Jan 2027Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome · Post Graduate Institute of Medical Education and Research, Chandigarh
Feb 2027Real-World Effectiveness of Depemokimab in Allergic Bronchopulmonary Aspergillosis With Severe Eosinophilic Asthma · Qianfoshan Hospital
Jun 2027Real-World Effectiveness of Tezepelumab in Allergic Bronchopulmonary Aspergillosis · Qianfoshan Hospital
Jul 2027Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis · Qianfoshan Hospital

Who these studies take

Of the 10 Aspergillosis, Allergic Bronchopulmonary studies recruiting now, 7 (70%) set no upper age limit and 1 (10%) stop at 75 or younger. 1 (10%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (20%) take healthy volunteers.

Recruiting studies that take each age, of 10
Age	Women	Men
10	0 (0%)	0 (0%)
18	10 (100%)	10 (100%)
30	10 (100%)	10 (100%)
40	10 (100%)	10 (100%)
50	10 (100%)	10 (100%)
65	10 (100%)	10 (100%)
75	10 (100%)	10 (100%)
85	8 (80%)	8 (80%)

Across all 42 studies, recruiting or not: 40% stop at 75 or younger and 21% at 65; 29% take children; 0% are for women only and 0% for men only; 14% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 42 of 42. search them.